BridgeBio Pharma (BBIO) Dividends Paid - Common (2019)
BridgeBio Pharma's (BBIO) quarterly Dividends Paid - Common came in at $54.0 million in Q3 2019, up 5317.65% quarter-over-quarter from $997000.0 in Q1 2019.
BridgeBio Pharma (BBIO) Dividends Paid - Common (2019) Analysis & Trends
BridgeBio Pharma has disclosed Dividends Paid - Common across 1 years of filings, most recently posting $54.0 million for Q3 2019.
- Dividends Paid - Common for Q3 2019 came in at $54.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $55.0 million (changed N/A YoY), and the FY2020 annual result was $5.0 million, down 90.91% from the prior year.
- Dividends Paid - Common came in at $54.0 million for Q3 2019 at BridgeBio Pharma, up from $997000.0 in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $54.0 million in Q3 2019 to a low of $997000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BridgeBio Pharma | 12.90 Bn | 11.97 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 54.01 Mn |
| Sep 30, 2019 | 54.01 Mn |
| Mar 31, 2019 | 997,000.00 |
| Mar 31, 2019 | 997,000.00 |